The present invention relates to the use of SHIP1 inhibitors and pan-SHIP1/2 inhibitors in various methods, including, without limitation: (i) a method to treat obesity or reduce body fat of an obese subject; (ii) a method to limit bone development in a subject suffering from an osteopetrotic or sclerotic disease; (iii) a method to treat or prevent diabetes; (iv) a method to reduce glucose intolerance or insulin resistance; and (v) a method to lower cholesterol.
本发明涉及在各种方法中使用SHIP1
抑制剂和全SHIP1/2
抑制剂,包括但不限于:(i) 一种治疗肥胖或减少肥胖患者体脂的方法;(ii) 一种限制骨发育的方法,适用于患有骨质增生病或硬化疾病的患者;(iii) 一种治疗或预防糖尿病的方法;(iv) 一种减少
葡萄糖耐量或
胰岛素抵抗的方法;以及(v) 一种降低
胆固醇的方法。